Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model

• Main Authors: Sanjay Basu, MD (Author), David Flood, MD (Author), Pascal Geldsetzer, MD (Author), Michaela Theilmann, MA (Author), Maja E Marcus, MA (Author), Cara Ebert, PhD (Author), Mary Mayige, MBChB (Author), Roy Wong-McClure, MD (Author), Farshad Farzadfar, MD (Author), Sahar Saeedi Moghaddam, MS (Author), Kokou Agoudavi, MD (Author), Bolormaa Norov, MSc (Author), Corine Houehanou, PhD (Author), Glennis Andall-Brereton, PhD (Author), Mongal Gurung, PhD (Author), Garry Brian, MD (Author), Pascal Bovet, MD (Author), Joao Martins, PhD (Author), Rifat Atun, ProfFRCP (Author), Till Bärnighausen, ProfMD (Author), Sebastian Vollmer, ProfPhD (Author), Jen Manne-Goehler, MD (Author), Justine Davies, ProfMD (Author)
• Format: Book
• Published: Elsevier, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Given the increasing prevalence of diabetes in low-income and middle-income countries (LMICs), we aimed to estimate the health and cost implications of achieving different targets for diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors am...